Dr Reddy`s Laboratories trades higher on eyeing to enhance presence in emerging segments like nutraceuticals
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Dr. Reddy's Laboratories is currently trading at Rs. 5176.55, up by 12.35 points or 0.24% from its previous closing of Rs. 5164.20 on the BSE.
The scrip opened at Rs. 5111.45 and has touched a high and low of Rs. 5190.45 and Rs. 5111.45 respectively. So far 2470 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5272.35 on 07-Jul-2023 and a 52 week low of Rs. 3996.10 on 19-Sep-2022.
Last one week high and low of the scrip stood at Rs. 5272.35 and Rs. 5042.65 respectively. The current market cap of the company is Rs. 86237.44 crore.
The promoters holding in the company stood at 26.70%, while Institutions and Non-Institutions held 50.30% and 11.70% respectively.
Dr Reddy's Laboratories is eyeing to enhance its presence in various emerging segments like nutraceuticals and aims to get into integrated digital healthcare services as part of its future growth plans.
It is exploring business spaces that will shape the healthcare of the future. These include deepening its presence in nutraceuticals, cell and gene therapy and new chemical entities (NCEs). The drug firm is also exploring new spaces such as integrated digital healthcare services, digital therapeutics, and disease management.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
